Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study.
Authors
Salles, GGopal, A
Schuster, S
Trotman, J
Hess, G
Hou, JZ
Yacoub, A
Lill, M
Martin, P
Vitolo, U
Spencer, A
Radford, John A
Jurczak, W
Morton, J
Osmanov, D
Caballero, D
Desphande, S
Vermeulen, J
Damle, R
Schaffer, M
Balasubramanian, S
Cheson, B
Fowler, N
Affiliation
Univ Lyon, Hosp Civils Lyon, Pierre Benite, FranceIssue Date
2017